INDIVIOR PHARMACEUTICALS INC
INDV · NASDAQ
Updated at 2026-10-14 10:03:30
- Today's High
- $36.26
- Today’s Low
- $35.19
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $36.00
- Previous Close
- $36.06
- Volume
- 7.47M
- Market Cap
- $4.25B
- P/E Ratio
- 12.02X
- EPS
- $2.77
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, UNITED STATES, 23235
- Country
- US
- Listing Date
- 2023-06-12
- Fiscal Year End
- December
- Shares Outstanding
- 121M
- CIK
- 0001625297
- Website
- www.indivior.com
Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company is headquartered in North Chesterfield, Virginia.
Financial Metrics
Revenue
2026-06-30
$343M
2026-03-31
$317M
2025-12-31
$358M
2025-09-30
$314M
Operating Expenses
2026-06-30
$134M
2026-03-31
$140M
2025-12-31
$172M
2025-09-30
$153M
Net Income
2026-06-30
$122M
2026-03-31
$89M
2025-12-31
$102M
2025-09-30
$42M
Net Profit Margin
2026-06-30
35.56%
2026-03-31
28.07%
2025-12-31
28.49%
2025-09-30
13.37%
Earnings Per Share
2026-06-30
$1.15
2026-03-31
$0.96
2025-12-31
$0.82
2025-09-30
$0.72
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$165M
2026-03-31
$126M
2025-12-31
$92M
2025-09-30
$54M
Effective Tax Rate
2026-06-30
23.75%
2026-03-31
22.6%
2025-12-31
-25.92%
2025-09-30
-13.51%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $343M | $317M | $358M | $314M |
| Operating Expenses | $134M | $140M | $172M | $153M |
| Net Income | $122M | $89M | $102M | $42M |
| Net Profit Margin | 35.56% | 28.07% | 28.49% | 13.37% |
| Earnings Per Share | $1.15 | $0.96 | $0.82 | $0.72 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $165M | $126M | $92M | $54M |
| Effective Tax Rate | 23.75% | 22.6% | -25.92% | -13.51% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.